Cencora, Inc. (ETR:ABG)

Market Cap	60.40B
Revenue (ttm)	273.87B
Net Income (ttm)	1.32B
Shares Out	n/a
EPS (ttm)	6.78
PE Ratio	45.60
Forward PE	20.50
Dividend	2.17 (0.91%)
Ex-Dividend Date	Nov 14, 2025

Volume	3,323
Average Volume	14
Open	238.60
Previous Close	240.35
Day's Range	233.55 - 240.35
52-Week Range	239.20 - 322.40
Beta	n/a
RSI	68.66
Earnings Date	n/a

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ABG

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD